CorMedix (CRMD) EBITDA Margin (2015 - 2025)
CorMedix (CRMD) recorded EBITDA Margin of 54.11% in Q4 2025, up 12.09 percentage points from 42.02% a year earlier and up 1.26 percentage points from the prior quarter.
Powered by 
Analysis
CorMedix (CRMD) EBITDA Margin (2015 - 2025) Analysis & Trends
For FY2025, CorMedix reported EBITDA Margin of 52.84%, up 103.46 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +11377.79 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -50.61% in FY2024, -46690.54% in FY2022 (-31305.44 pp) and -15385.10% in FY2021 (-4060.15 pp).
- The Q4 2025 figure is the highest quarterly EBITDA Margin since Q4 2018.
- On a year-over-year basis, EBITDA Margin has increased for three consecutive quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 32987.03 percentage points in Q2 2022, against a drop of 83673.66 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 52.85% (Q3 2025), 49.59% (Q2 2025) and 51.91% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | CorMedix | 609.51 Mn | -43.01 Mn | 77.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 54.11% |
| Sep 30, 2025 | 52.85% |
| Jun 30, 2025 | 49.59% |
| Mar 31, 2025 | 51.91% |
| Dec 31, 2024 | 42.02% |
| Sep 30, 2024 | -28.02% |
| Jun 30, 2024 | -1,894.99% |
| Dec 31, 2022 | -28,168.85% |
| Sep 30, 2022 | -101,813.86% |
| Jun 30, 2022 | -38,676.32% |
| Mar 31, 2022 | -91,829.61% |
| Dec 31, 2021 | -13,759.37% |
| Sep 30, 2021 | -22,441.07% |
| Jun 30, 2021 | -71,663.35% |
| Mar 31, 2021 | -8,155.95% |
| Dec 31, 2020 | -10,776.39% |
| Sep 30, 2020 | -7,088.32% |
| Jun 30, 2020 | -54,133.67% |
| Mar 31, 2020 | -7,554.04% |
| Dec 31, 2019 | -21,628.48% |
API Access
CorMedix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();